• Contribution of Latin America to Mental Health in Pregnancy

    Nov 1, 2013, 00:00

  • Breast Cancer Screening Program in the Basque Country- Costs and Health Benefits Assessment Through Discrete Event Simulation

    Nov 1, 2013, 00:00

  • The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life

    Nov 1, 2013, 00:00

  • GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

    Nov 1, 2013, 00:00

  • Assessing Quality of Life in Adult Growth Hormone Deficiency- Further Development of the QoL-AGHDA

    Nov 1, 2013, 00:00

  • The Impact of Chlamydia and Gonorrhoea Point of Care Nucleic Acid Amplification Tests on Clinical Pathways and Costs in Genito-Urinary Medicine Clinics in the United Kingdom

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Cushing’s Disease in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United States

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Multifocal and Monofocal Intraocular Lenses in Cataract Surgery in the Czech Republic

    Nov 1, 2013, 00:00

  • Adherence to Disease-Specific Recommendations for Pharmacoeconomic Studies in Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Burden of Actinic Keratosis in Germany-Results of a Literature Research

    Nov 1, 2013, 00:00

  • Modelización Económica Del Genotipado Del Citocromo P450 Con El Test Brainchip En El Tratamiento De La Depresión Mayor

    Nov 1, 2013, 00:00

  • Cost of Cancer in the Austrian Hospital Setting

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Tratamiento Profiláctico Versus a Demanda En Adolescentes Con Hemofilia a Severa En Colombia

    Nov 1, 2013, 00:00

  • Pricing and Reimbursement Analysis of Lifestyle Medicines in Serbia

    Nov 1, 2013, 00:00

  • Mortality and Medical Costs Associated with Liver-Related Diseases Among Patients with Hepatitis C Virus(HCV) Infection in Taiwan

    Nov 1, 2013, 00:00

  • Economic Evaluation of the Treatment Compliance in Patients with Parkinson’s Disease Received Different Preparations of Levodopa

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Uso De Pruebas Treponémicas Rápidas Para La Detección Y Tratamiento Temprano De Sífilis Gestacional En Colombia

    Nov 1, 2013, 00:00

  • Value of Life- As Perceived by Physicians and the General Public

    Nov 1, 2013, 00:00

  • Resource Utilisation and Costs of Total Hip Arthroplasty in the United Kingdom- A Descriptive Analysis

    Nov 1, 2013, 00:00

  • Methodological Challenges in Multi-Criteria Decision Analysis (MCDA) for Health Policy Decision-Making- A Systematic Review

    Nov 1, 2013, 00:00

  • Budget Impact of Everolimus for Tuberous Sclerosis Complex (TSC) Related Angiomyolipoma (AML)- United Kingdom Perspective

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Ferumoxytol in the Management of Anemia in Patients with Chronic Kidney Disease in Belgium

    Nov 1, 2013, 00:00

  • Baseline Patient, Ocular Features and Management of a Patient Population Diagnosed with Vitreomacular Traction- An Observational Study in Flanders

    Nov 1, 2013, 00:00

  • Variations in the Health Status of Irish Regions

    Nov 1, 2013, 00:00

  • Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De Trasplantes

    Nov 1, 2013, 00:00

  • Examining the Relationship Between Country-Level Factors and Vaccine Wastage- A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

    Nov 1, 2013, 00:00

  • Initial Anticoagulation Therapy in Patients with Venous Thromboembolism and Impaired Renal Function- Results of an Observational Study

    Nov 1, 2013, 00:00

  • Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Basiliximab As Induction Therapy for Kidney Transplantation in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant Patients

    Nov 1, 2013, 00:00

  • Efficacy of Fingolimod in Delaying Confirmed Disability Progression in Patients Failing Prior Treatment- A Markov Model Application to Estimate Time to Disability Health States

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Stribild Compared to Similar Antiretroviral Therapies in a Specialty Retail Pharmacy

    Nov 1, 2013, 00:00

  • Early-Stage Economic Evaluation of Stratified Medicine in Multiple Myeloma

    Nov 1, 2013, 00:00

  • Evaluation of Acute Pancreatitis Signals with Incretin Enhancers- Revisiting Disproportionality Analysis of the Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome

    Nov 1, 2013, 00:00

  • United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications

    Nov 1, 2013, 00:00

  • Diabetic Patients in Primary Care- Self-Perception and Satisfaction. Comparative Study Spain Versus Europe

    Nov 1, 2013, 00:00

  • Correlations Between Changes in the Urticaria Activity Score (UAS7) and the Dermatology Life Quality Index (DLQI) from Baseline to 28 or 40 Weeks- Comparisons of Trajectories of Change in Patients with Chronic Spontaneous/Idiopathic Urticar ...

    Nov 1, 2013, 00:00

  • A Discrete Choice Experiment to Evaluate Blood Glucose Meter Preferences in People with Type 1 and Type 2 Diabetes in the United Kingdom

    Nov 1, 2013, 00:00

  • Long-Term Survival After Intensive Care Unit Discharge in Thailand- A Retrospective Study

    Nov 1, 2013, 00:00

  • Results of Galata Study- Galvus Efficacy and Safety Assessment in Turkish Population

    Nov 1, 2013, 00:00

  • Usefulness of a Commercial Hospital Claims Database to Identify Current Anti-Vascular Endothelial Growth Factor Treatment Patterns in Patients with Exudative Age-Related Macular Degeneration in Japan

    Nov 1, 2013, 00:00

  • Utilization of Routine Data for Regionalized Epidemiology in Austria - The Example of Ischemic Heart Disease (ICD9 410-414)

    Nov 1, 2013, 00:00

  • Localization of Activities and Equivalence of Movement in Clinical Outcomes Assessments

    Nov 1, 2013, 00:00

  • Change of Burden of Disease in German Rheumatoid Arthritis Patients Since the Uptake of TNF-Inhibitors- A Literature Review of German Real Life Data

    Nov 1, 2013, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Key Design and Operational Considerations for Successful Conduct

    Nov 1, 2013, 00:00

  • Weight- and Health-Related Quality of Life (WRQoL and HRQoL) with Canagliflozin (CANA) Versus Sitagliptin (SITA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Background Metformin

    Nov 1, 2013, 00:00

  • Cost Saving After Sutureless Replacement in Aortic Valve Stenosis- Results from a Propensity-Matched Score Analysis in Germany

    Nov 1, 2013, 00:00

  • Analysis of Public and Private Hospital Databases (PMSI) 2010 / 2011 to Estimate the Frequency and Associated Costs for Febrile Neutropenia in France

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Actinic Keratoses

    Nov 1, 2013, 00:00

  • Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico

    Nov 1, 2013, 00:00

  • Burden of Informal Care in Relation to Disease Activity and Disability in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France

    Nov 1, 2013, 00:00

  • Choosing Health States for Elicitation of Population Preferences for the EQ-5D

    Nov 1, 2013, 00:00

  • Patient-Reported Outcomes- Are They Worth It? An Examination in Pro Value Through Case Studies

    Nov 1, 2013, 00:00

  • When Treatment Is Mitigated by Adverse Events- The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/Ribavirin

    Nov 1, 2013, 00:00

  • Patterns in Asthma Medicationtreatment in the United States

    Nov 1, 2013, 00:00

  • Evaluation of a Process of Care Model for Open Intravesical Ureteral Reimplantation from a Contemporary Health Care Perspective

    Nov 1, 2013, 00:00

  • Is External Price Referencing an Appropriate Drug Policy from an Efficiency, Equity, and Quality Perspective?

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Isolated Aortic Valve Replacements Associated with the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in France and United Kingdom

    Nov 1, 2013, 00:00

  • Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Five European Countries

    Nov 1, 2013, 00:00

  • Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer Patients

    Nov 1, 2013, 00:00

  • Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s Disease

    Nov 1, 2013, 00:00

  • Herpes Zoster in Europe- A Review of Evidence Documenting Humanistic, Economic and Societal Burden

    Nov 1, 2013, 00:00

  • Bayesian Evidence Synthesis of Safety Data- A Robust Option?

    Nov 1, 2013, 00:00

  • Functional Observation with TTO in Chronic Diseases

    Nov 1, 2013, 00:00

  • Risk Sharing for Innovative Pharmaceuticals Within Social Health Insuran Experiences from China

    Nov 1, 2013, 00:00

  • A Cost of a Childbirth with in vitro Fertilization in Poland

    Nov 1, 2013, 00:00

  • Analysis of Health Care Costs in Elderly Patients with Multiple Chronic Conditions Using a Finite Mixture of Generalized Linear Models

    Nov 1, 2013, 00:00

  • Self-Reported Population Health- An International Perspective Based on EQ-5D

    Nov 1, 2013, 00:00

  • Novel Pricing Strategies to Support Sustainable Access to Medicine in Latin America

    Nov 1, 2013, 00:00

  • Patient Preferences Regarding Monitoring and Treatment for the Management of Neovascular Age-Related Macular Degeneration

    Nov 1, 2013, 00:00

  • Draft Versus Final Guidance in Nice’s Drug Technology Appraisal Process

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder I Patients with Mixed Episodes

    Nov 1, 2013, 00:00

  • Análise De Custo-Efetividade Para Utilização De Oclusores Septais No Fechamento De Comunicação Interatrial (CIA) Do Tipo Ostium Secundum Comparado Com a Cirurgia Convencional

    Nov 1, 2013, 00:00

  • An Excel Calculator to Estimate Rheumatoid Arthritis Costs in Turkey

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Screening and Treatment of Hyperlipidemia in Chinese Adults Aged 45 and Above

    Nov 1, 2013, 00:00

  • Cost-Analysis in the Treatment of Patients Affected by Malignant Ascites in Italy

    Nov 1, 2013, 00:00

  • Budget Impact of HPV16/18 Genotyping Tests for the Management of Non-concordant Cotesting Cervical Cancer Screening Results- A United States Payer Perspective

    Nov 1, 2013, 00:00

  • A Health Economic Evaluation of Fenofibric Acid in Combination with Statins in the Prevention of Cardiovascular Disease in Taiwanese Mixed Hyperlipidemia Patients

    Nov 1, 2013, 00:00

  • Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors- The Equade Study

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life in Patients with Type 1 Diabetes and Impaired Hypoglycaemia Awareness- The Role of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension

    Nov 1, 2013, 00:00

  • Value Attributes of Generic Versus Branded Drugs in São Paulo, Brazil

    Nov 1, 2013, 00:00

  • Health Care Resource Usage, Treatment and Costs Among Patients with Hip Fracture in the United Kingdom

    Nov 1, 2013, 00:00

  • Costs of Acute Heart Failure in France

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Erlotinib En El Tratamiento De Pacientes Con Cáncer Pulmonar De Células No Pequeñas, CPCNP, Con Mutación Del Gen EGFR+, En Colombia

    Nov 1, 2013, 00:00

  • What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish Setting

    Nov 1, 2013, 00:00

  • Health Care Utilization and Expenditures of Osteoporosis Patients Treated with Oral Bisphosphonate in Tianjin, China

    Nov 1, 2013, 00:00

  • Pro Claims in Japanese Oncology Product Labeling

    Nov 1, 2013, 00:00

  • A Review of the Application of International Reference Pricing in Ukraine’s Pilot Hypertension Reimbursement Scheme

    Nov 1, 2013, 00:00

  • The Impact of Generic Substitution on Health Outcomes and Costs- A Systematic Review

    Nov 1, 2013, 00:00

  • Impact of Highly Active Antiretroviral Therapy (HAART) Regimen on Adherence and Risk of Hospitalization in Veterans with HIV/AIDS

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Increasing Statin Adherence for Primary and Secondary Prevention in Community Pharmacies

    Nov 1, 2013, 00:00

  • A Systematic Review and Network Meta-Analysis of Second-Line Anti-Diabetes Treatments for Those with Type 2 Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy

    Nov 1, 2013, 00:00

  • Social Network Analysis of Authorship Networks and the Identification of Expert Advisors

    Nov 1, 2013, 00:00

  • The Cost Implications of Renal Denervation Therapy at the Hospital Level in the United Kingdom

    Nov 1, 2013, 00:00

  • A Budget Impact Analysis (BIA) of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk Patients with Syntomatic Severe Valve Stenosis (SSVS) Under the Brazilian Public Health Care System (SUS) Perspective

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Post-Traumatic Stress Disorder in the United States

    Nov 1, 2013, 00:00

  • Impact of Using Either Multiplicative or Additive Utility Decrements in Decision Models

    Nov 1, 2013, 00:00

  • Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database

    Nov 1, 2013, 00:00

  • To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Fesoterodine and Tolterodine for the Treatment of Overactive Bladder with Urge Urinary Incontinence in Spain and Finland

    Nov 1, 2013, 00:00

  • Health Related Quality of Life at Six Months Post Discharge in Patients with Heart Failure

    Nov 1, 2013, 00:00

  • Cost of Achieving Relevant Composite Endpoint of HbA1c7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus Glipizide

    Nov 1, 2013, 00:00

  • Adherence and Resource Use Among Patients Treated with Biologics. Findings from the Beetle Study (Biological Drugs- Evaluation of Economics, Treatments, and Labeling in Real-World Setting)

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia

    Nov 1, 2013, 00:00

  • Societal Burden of Hysterectomy in Reproductive-Aged Women with Uterine Fibroids

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Vaccination Against Herpes Zoster and Postherpetic Neuralgia- A Critical Review

    Nov 1, 2013, 00:00

  • Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia- A Literature Update

    Nov 1, 2013, 00:00

  • A Systematic Review of Patient Preferences for Subcutaneous Medications

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Peak and Trough Effects of Bimatoprost 0.03%/Timolol 0.5% Preservative-Free Fixed Combination for the Treatment of Open-Angle Glaucoma and Ocular Hypertension

    Nov 1, 2013, 00:00

  • Analysis of Consumption of Antihypertensive Drugs in Serbia from 2007 to 2011

    Nov 1, 2013, 00:00

  • Patterns of Generic and Proprietary Prescribing of Statins Over Time in England

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban in the Treatment of Atrial Fibrillation in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paricalcitol Versus Parathyroidectomy for Secondary Hyperparathyroidism to Chronic Kidney Disease in Mexico

    Nov 1, 2013, 00:00

  • Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic Diseases

    Nov 1, 2013, 00:00

  • Evaluating Whether Inconsistencies Are Present in a Mixed Treatment Comparison of Trough Forced Expiratory Volume in 1 Second at 12 Weeks

    Nov 1, 2013, 00:00

  • Health Economic Evaluation of a Complementary Biomarker for Hypothetical Prostate Cancer Screening in Germany

    Nov 1, 2013, 00:00

  • A Comparison of the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Hypertension in the United States

    Nov 1, 2013, 00:00

  • Analysis of Re-Hospitalisations for Stroke and Transient Ischemia Recurrence and Associated Costs in the Burgundy Region in France

    Nov 1, 2013, 00:00

  • The Resource Use Related to Hip Fractures Based on Data from ICUROS

    Nov 1, 2013, 00:00

  • Costs of Incidence-Based Central Retinal Vein Occlusion in France

    Nov 1, 2013, 00:00

  • Assessment of a Canadian Primary Care Electronic Medical Record Database for Use in Observational Studies

    Nov 1, 2013, 00:00

  • Modeling a Switch from Trivalent to Quadrivalent Influenza Vaccine in Canada and the United Kingdom

    Nov 1, 2013, 00:00

  • Natalizumab for 2nd Line Treatment in Relapsing-Remitting Multiple Sclerosis Patients- 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective

    Nov 1, 2013, 00:00

  • Analysis of Causal Relations in Stroke Registry Data

    Nov 1, 2013, 00:00

  • Comorbidity Influence in the Control of Arterial Hypertension

    Nov 1, 2013, 00:00

  • Real World Outcomes in Type 2 Diabetes- Lower Cost of Treating Patients to A1c7% with Liraglutide Versus Exenatide

    Nov 1, 2013, 00:00

  • Comparing the Potential Budget Impact of Novel Therapies for Advanced Melanoma in Second-Line Under Brazilian Private Health Care System Perspective

    Nov 1, 2013, 00:00

  • Use of Clinical Practice Guidelines by Physicians in Japan

    Nov 1, 2013, 00:00

  • Appetite Suppressants- A Drug Utilisation Study

    Nov 1, 2013, 00:00

  • Urban Health Networks and Perinatal Health Risk in Argentina

    Nov 1, 2013, 00:00

  • Consistency of Current Type 2 Diabetes (T2DM) Treatment Patterns in General Practice Versus the 2013 French Has T2DM Guidelines- A Transversal Study Based on the French IMS LifelinkTM Prospective Diabetes Cohort

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Universal Screening for Thyroid Disease in Pregnant Women in Spain

    Nov 1, 2013, 00:00

  • Preliminary Italian Archive of Eq-5d Data on Individuals from the General Population and with Different Disease Conditions

    Nov 1, 2013, 00:00

  • The Economic Assessment of an Environmental Intervention- Discrete Deployment of Copper for Infection Control in ICUs

    Nov 1, 2013, 00:00

  • The Cost Saving Potential of Utilizing Biosimilar Medicines in Biologic Naive Severe Rheumatoid Arthritis Patients

    Nov 1, 2013, 00:00

  • Modelling the Predictive Value of Pain Intensity on Costs and Resources Utilization in Patients with Peripheral Neuropathic Pain

    Nov 1, 2013, 00:00

  • Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic Fibrosis

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Approved Biologic Interventions for the Induction of Response in Ulcerative Colitis

    Nov 1, 2013, 00:00

  • A De Novo Economic Model to Assess the Cost and Quality of Life Consequences of an Intervention for Levodopa Induced Dyskinesia Amongst Patients with Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Cost-Utility of Pediatric Cochlear Implantation in Hungary

    Nov 1, 2013, 00:00

  • The Cost of NSCLC in France

    Nov 1, 2013, 00:00

  • The Impact of Cost Effectiveness on Reimbursement Approvals in Fran A Comparison of France and the United Kingdom

    Nov 1, 2013, 00:00

  • The Pharmacoeconomic of Cardiology in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Universal Vaccination Against Varicella in the Netherlands

    Nov 1, 2013, 00:00

  • Resource Utilization and Costs Associated with Rituximab Treatment in Patients with Pemphigus and Pemphigoid- A Comparison of 6 Months Before and 6 Months After Treatment

    Nov 1, 2013, 00:00

  • Health Economics Assessment of Rilpivirine Versus Comparators as First-Line Antiretroviral Therapies in HIV-1 Patients with a Viral Load (VL) ≤100,000 Copies/mL in France

    Nov 1, 2013, 00:00

  • Unchartered Territory – Analysis of Cross-Border Service Provision Within Public Health Systems

    Nov 1, 2013, 00:00

  • Defining the Patient Journey via Claims Analysis in an Orphan Ophthalmic Condition- Is There a Standard of Care?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)

    Nov 1, 2013, 00:00

  • Real-World Utilization Data Over 4 Years of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration in Canada

    Nov 1, 2013, 00:00

  • Burden of Herpes Zoster and Post-Herpetic Neuralgia in Sweden

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for the Prevention of Stroke- An Analysis of Patients with Atrial Fibrillation in Greece

    Nov 1, 2013, 00:00

  • Modelo Predictivo Para La Identificación Temprana De Población En Riesgo De Cronificar En Una Administradora De Riesgos Laborales En Colombia

    Nov 1, 2013, 00:00

  • Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled Trial

    Nov 1, 2013, 00:00

  • Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer Database

    Nov 1, 2013, 00:00

  • A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan

    Nov 1, 2013, 00:00

  • The Structure and Process of Work of Spanish Regional Comittees Assessing Medicines- Preliminary Results

    Nov 1, 2013, 00:00

  • Impact of Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens in the Management of Advanced Esophago-Gastric Cancer in Hong Kong

    Nov 1, 2013, 00:00

  • Chronic Patients’ Willingness to Pay for an Alternative Drug with Innovative Characteristics

    Nov 1, 2013, 00:00

  • Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico- A Comparison to Sweden

    Nov 1, 2013, 00:00

  • Análisis Del Gasto Sanitario Español 1980-2010

    Nov 1, 2013, 00:00

  • Impact of Treatment Failure on the Total Cost of Triple Therapy Including Boceprevir or Telaprevir Based on the French Early Access Program (ANRS CO20-CUPIC) Study

    Nov 1, 2013, 00:00

  • Alternative High Level Disinfectants to Processing Flexible Endoscopes

    Nov 1, 2013, 00:00

  • Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review

    Nov 1, 2013, 00:00

  • Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs- The Case of Trastuzumab in Seven Latin American Countries

    Nov 1, 2013, 00:00

  • Meta-analysis of BCG Vaccine Efficacy for Infants in Ireland

    Nov 1, 2013, 00:00

  • Estimating the Budget Impact in Brazilian Public Health Care System of Tocilizumab Reimbursement As a Rheumatoid Arthritis First-Line Biological Therapy

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Anti-Inhibitor Coagulant Complex (AICC) in the Treatment of Inhibitor Hemophilia

    Nov 1, 2013, 00:00

  • Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South Africa

    Nov 1, 2013, 00:00

  • Annual Expenditure on Anti-Tnf Treatment of Rheumatoid Arthritis for the Public Health System in Brazil

    Nov 1, 2013, 00:00

  • Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting

    Nov 1, 2013, 00:00

  • ISPOR 16th Annual European Congress Disclosure Information

    Nov 1, 2013, 00:00

  • Current Characteristics, Treatment and Health Care Consumption of Patients with Asthma or COPD in the Netherlands

    Nov 1, 2013, 00:00

  • A Micro-Costing of the Inpatient Management of Febrile Neutropenia in the Irish Health Care Setting

    Nov 1, 2013, 00:00

  • Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom- A CPRD-Based Study

    Nov 1, 2013, 00:00

  • UK Quality Outcomes Framework (QOF) Thresholds and Elevated HbA1c Levels Among Patients with Type II Diabetes - A Longitudinal Study Using the Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Tecepoc Study. How to Improve the Inhalation Techniques in Patient with COPD. The Influence of Preferences

    Nov 1, 2013, 00:00

  • Economic Impact Associated with a Biological Therapy Prioritization Protocol in Rheumatoid Arthritis Patients in the Hospital of Sagunto

    Nov 1, 2013, 00:00

  • Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • Workshop in Pharmacoeconomics- An Italian Experience of Multi-Stakeholder Hta Consensus

    Nov 1, 2013, 00:00

  • Economic Evaluation of Insulin Lispro Mix 25 with Glargine in the Treatment of Type 2 Diabetes Mellitus Patients in the Mexican Public Health Care System in Mexico

    Nov 1, 2013, 00:00

  • Impact on the Estimated ICER of Including Age-Specific Baseline HRQoL in a Model

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Estrategias De Prevención Primaria Y Secundaria Para Cáncer De Cuello Uterino En Colombia

    Nov 1, 2013, 00:00

  • Effects of Claims-Based Rheumatoid Arthritis Severity on Biologic Therapy Use and Health Care Costs in Turkey

    Nov 1, 2013, 00:00

  • Estimation of the Epidemiological and Economic Impact of the Quadrivalent HPV Vaccination in Girls and Boys in Spain

    Nov 1, 2013, 00:00

  • Off-Label Trastuzumab Usage in Breast Cancer Patient in Turkey

    Nov 1, 2013, 00:00

  • Determinants of Prompt Access to Health Care in CHPS Programme in Rural Communities of Bawjiase, Ghana

    Nov 1, 2013, 00:00

  • Descripción De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) Dentro De Un Programa De Atención En Un Centro Especializado En Colombia

    Nov 1, 2013, 00:00

  • Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector Perspective

    Nov 1, 2013, 00:00

  • A Model of the Cost Effectiveness of Infliximab for the Treatment of Severely Active Ulcerative Colitis, in Children and Adolescents Aged 6 to 17 Years, Who Have Had an Inadequate Response to Conventional Therapy

    Nov 1, 2013, 00:00

  • Responsiveness of the EQ-5D in Oncology- A Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost-Utility of Granulocyte-Colony Stimulating Factors (G-CSFs) for Primary Prophylaxis (PP) of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in the Netherlands

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of the United States Veteran Patients Diagnosed with Schizophrenia

    Nov 1, 2013, 00:00

  • Cost of Intensive Care Stay in Turkey- In the View of Payer and Health Care Provider

    Nov 1, 2013, 00:00

  • Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease- A Reliability Study with the PROQOL-HIV Questionnaire

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treating Neovascular Age-Related Macular Degeneration in an Italian Setting

    Nov 1, 2013, 00:00

  • The Humanistic and Economic Burden of Venous Thromboembolism in Pregnant Women- A Systematic Review

    Nov 1, 2013, 00:00

  • Natalizumab Treatment Is Associated with Reduced Neurology Outpatient Appointments, Unplanned Hospital Admissions and Length of Stay

    Nov 1, 2013, 00:00

  • Economic Implications of Alternative Treatments and Care Locations for Acute Bacterial Skin and Skin Structure Infections with Suspected MRSA

    Nov 1, 2013, 00:00

  • Elicitation of Health-Related Quality of Life Concepts Associated with Overactive Bladder

    Nov 1, 2013, 00:00

  • Dispensation Channels of Anti-TNFs in Inflammatory Bowel Disease

    Nov 1, 2013, 00:00

  • Systematic Review Approaches for HTA- Horses for Courses?

    Nov 1, 2013, 00:00

  • Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients?

    Nov 1, 2013, 00:00

  • A Deterministic Model to Evaluate the Costs for Surgical Procedures- The Win-Win Model

    Nov 1, 2013, 00:00

  • Estimating the Budget Impact of Adding Avastin (Bevacizumab) to Front Line Treatment for Advanced Ovarian Cancer in Brazilian Supplementary Health Care System

    Nov 1, 2013, 00:00

  • Requirement of Cancer Help Lines in India and the Perception of All the Stake Holders

    Nov 1, 2013, 00:00

  • Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement Surgery

    Nov 1, 2013, 00:00

  • Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada

    Nov 1, 2013, 00:00

  • Short and Long-Term Cost-Effectiveness of Switching Therapy from Insulin Glargine to Insulin Detemir in People with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Vaccine Timeliness- A Cost Analysis of the Implications of Delayed Vaccination

    Nov 1, 2013, 00:00

  • The Relationship Between Specific Annual Bleed Rates and Health Outcomes Among Children with Severe Hemophilia a in Latin America

    Nov 1, 2013, 00:00

  • Lymphedema – the Long Way to Diagnosis and Therapy

    Nov 1, 2013, 00:00

  • Similarities and Differences Across Same Language Questionnaires for Different Countries- Linguistic Validation of the Asthma Symptom Diary (ASD) and Kidney Disease and Quality of Life (KD-QOL-36)

    Nov 1, 2013, 00:00

  • Parecer Técnico-Científico- Eficácia E Segurança Do Uso Do Rituximabe No Tratamento De Leucemia Linfocítica Crônica

    Nov 1, 2013, 00:00

  • An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension Complications

    Nov 1, 2013, 00:00

  • Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health Services

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in Canada

    Nov 1, 2013, 00:00

  • High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity- Baseline Results from the Rapid-PSA Study

    Nov 1, 2013, 00:00

  • Are Head-To-Head Data Necessary to Gain Reimbursement in the French National Health Care System?

    Nov 1, 2013, 00:00

  • Costs of Alternative Methods of Child Delivery in Serbia

    Nov 1, 2013, 00:00

  • The Relationship Between Irritable Bowel Syndrome with Constipation Symptoms and Health-Related Quality of Life

    Nov 1, 2013, 00:00

  • Comparison of Alternative Methods of Resource-Use Data Collection for the Economic Evaluation of Health Care Interventions- A Case Study in Frail Older People

    Nov 1, 2013, 00:00

  • Cost Burden of Rotavirus Gastro-enteritis Requiring Hospitalizations in the Czech Republic and in Slovakia

    Nov 1, 2013, 00:00

  • Cost of End of Life Pharmacotherapy in Cancer Patients- Where Does the Budget Go To?

    Nov 1, 2013, 00:00

  • Drug Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Austria

    Nov 1, 2013, 00:00

  • Global Variations in Biologics Access and Rheumatoid Arthritis Treatment Costs

    Nov 1, 2013, 00:00

  • The Survey of the Japan-Style Premium Scheme in Pharmaceutical Pricing Decisions

    Nov 1, 2013, 00:00

  • The ‘Wound-QoL’- A Short Questionnaire Measuring Quality of Life in Patients with Chronic Wounds

    Nov 1, 2013, 00:00

  • Health Seeking Behavior Among Members of the Households; Case of Gucha South District, Kisii County, Kenya

    Nov 1, 2013, 00:00

  • Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents Versus Bare-Metal Stents- A Systematic Review

    Nov 1, 2013, 00:00

  • Factors Associated with Pain Persistence in Patient with Depression During a 3 –Month Follow-Up Period

    Nov 1, 2013, 00:00

  • Long-Term Cost Comparison Between Paricalcitol and Calcitriol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in Mexico

    Nov 1, 2013, 00:00

  • Comparing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis- A Brazilian Private Perspective

    Nov 1, 2013, 00:00

  • Mapping the CCQ onto EQ-5D Scores (Im)Possible?

    Nov 1, 2013, 00:00

  • Relationship Between Falls and CNS Drugs at a Acute Care Teaching Hospital in Japan

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

    Nov 1, 2013, 00:00

  • Burden of Cystic Fibrosis in the Russian Federation

    Nov 1, 2013, 00:00

  • Inflammatory Bowel Diseases in Italy- Incidence Trends and Patients’ Characteristics

    Nov 1, 2013, 00:00

  • Defining the Proper Methodology to Use in a Data-Peek for Power (DPP)

    Nov 1, 2013, 00:00

  • Disease-Modifying Therapies (DMT) for Multiple Sclerosis (MS)- Analysis of Its Evolution in Spain Between 2004 and 2012

    Nov 1, 2013, 00:00

  • Cost Analysis of Vaccination for Children in Ukraine

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Tocilizumab Monotherapy Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

    Nov 1, 2013, 00:00

  • Health and Economic Burden of Tobacco Use in Seven Latin American Countries- Results from a Microsimulation Health Economic Model (HEM)

    Nov 1, 2013, 00:00

  • The Cost of Osteoporotic Fractures in the Romanian Postmenopausal Women Population

    Nov 1, 2013, 00:00

  • Three Tools to Reduce the Impact of Common Decision-Making Biases When Considering Subgroup Analyses

    Nov 1, 2013, 00:00

  • Single Use Devices in Argentina- Economic Evaluation of a “Reuse” Versus a “Single Use” Policy

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Coronary Artery Calcium Score to Guide Statin Therapy in Patients with Elevated C-Reactive Protein and Low LDL Cholesterol Levels

    Nov 1, 2013, 00:00

  • Comparing the Efficacy of First and Second Generation Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis- A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Breast Cancer and Bone Metastasis from a United State Managed Care Organization Perspective

    Nov 1, 2013, 00:00

  • Personalized Health Care in France, Germany and the United Kingdom- Are Health Technology Assessment Agencies Ready?

    Nov 1, 2013, 00:00

  • Evaluation of the Herpes Zoster Impact as Comorbidity Factor in 5 Pathologies French Hospital Care Among Adults Aged 50 and Older

    Nov 1, 2013, 00:00

  • Utility Mapping of the EORTC QLQ-C30 onto EQ-5D in Patients with Soft Tissue Sarcoma

    Nov 1, 2013, 00:00

  • A Case Study of FDA Practices and Its Influence on Regulatory and Reimbursement Decisions for Darunavir

    Nov 1, 2013, 00:00

  • A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery

    Nov 1, 2013, 00:00

  • Persistence Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary- A Retrospective Cohort Study

    Nov 1, 2013, 00:00

  • Catheter-Associated Urinary Tract Infections- Cost Comparison Study from the Public Payer Perspective

    Nov 1, 2013, 00:00

  • Comparación Indirecta De La Efectividad De La Combinación De Hipoglucemiantes Asociados a Metformina En Pacientes Diabéticos Tipo 2

    Nov 1, 2013, 00:00

  • A Comparison of the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Diabetes in the United States

    Nov 1, 2013, 00:00

  • Burden of Hospitalization in Patients with Advanced Lung Cancer in the United States

    Nov 1, 2013, 00:00

  • Cost of Adults> 50 Years Community-Acquired Pneumonia in Argentina

    Nov 1, 2013, 00:00

  • Use of Antibiotics and Prescription Medication in Influenza Disease in the United Kingdom

    Nov 1, 2013, 00:00

  • The Current Management and Costs of Irritable Bowel Syndrome with Constipation in Belgium- A 2-Round Expert Survey

    Nov 1, 2013, 00:00

  • Overview of Health Economic Models in Type 2 Diabetes Mellitus (T2DM); A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed with Non-Psychotic Major Depressive Disorder- A Literature Review

    Nov 1, 2013, 00:00

  • A Retrospective Analysis of Drug Reimbursement Decisions in Ireland- A Multi Criteria Decision Analysis Approach

    Nov 1, 2013, 00:00

  • Economical Justification of the Innovation Method of Laboratory Diagnostic of the Structural and Functional Changes of Serum Albumin in Septic Complications (Ata-Test)

    Nov 1, 2013, 00:00

  • Methodology and Development of ‘Polish Dictionary of Quality of Life Terms’

    Nov 1, 2013, 00:00

  • Economic Evaluation of Epoetin Alfa Hexal (Binocrit) Compared to Darbepoetin Alfa (Aranesp) in the Treatment of Chemotherapy Induced Anemia (CIA) in Germany

    Nov 1, 2013, 00:00

  • Personalized Treatment in Heart Failure Disease Management Improves Outcomes and Reduces Costs

    Nov 1, 2013, 00:00

  • Fixed Reference Pricing or Benefit Assessment of Established Products – from the Frying Pan into the Fire?

    Nov 1, 2013, 00:00

  • Nurses’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • Specific Attributes of Pharmaceutical Care in England, Poland, Germany, Denmark, Italy and United States

    Nov 1, 2013, 00:00

  • Relevant Decision-Making Criteria in German Hospital Formularies

    Nov 1, 2013, 00:00

  • Economic Evaluation of Treatments for Chronic Hepatitis B

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program

    Nov 1, 2013, 00:00

  • Work Impairment Burden of Anxiety and Depression in Germany

    Nov 1, 2013, 00:00

  • Indirect Treatment Comparison Between Fixed-Dose-Combinations of Losartan/Amlodipine and Valsartan/Amlodipine in Blood Pressure Control

    Nov 1, 2013, 00:00

  • Comorbidities Associated to Atrial Fibrillation (AF) in Selected Latin America Countries

    Nov 1, 2013, 00:00

  • Value-Based Pricing in the UK and Potential Patient Access Hurdles to Innovative Drugs

    Nov 1, 2013, 00:00

  • Productivity Loss in Population of Informal Caregivers to Diabetic Foot Syndrome Patients in Poland

    Nov 1, 2013, 00:00

  • An Assessment of Unemployment Among People Living with HIV/AIDS in Canada and Europe

    Nov 1, 2013, 00:00

  • Telling the Inside Story- Activity and Performance Metrics for a Typical International Multi-Language Multi-Center Non-Interventional Study with the Intrial Data Capature System

    Nov 1, 2013, 00:00

  • Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of Kazakhstan

    Nov 1, 2013, 00:00

  • Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005

    Nov 1, 2013, 00:00

  • Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies- Optimising User Engagement and Addressing Payer Concerns

    Nov 1, 2013, 00:00

  • Structural Validity of a 14-Item Abridged Version of the Menopause Cervantes Health-Related-Quality-Of-Life Scale

    Nov 1, 2013, 00:00

  • C-Quality- A Cost and Quality of Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in Italy

    Nov 1, 2013, 00:00

  • Adjunctive Therapy with Pregabalin in Generalized Anxiety Disorder Patients with Partial Response to Ssri Treatment- A Cost-Consequences Analysis in Medical Practice in Spain

    Nov 1, 2013, 00:00

  • Astrological Signs and Health Problems; Demonstrating the Multiple Comparisons Problem

    Nov 1, 2013, 00:00

  • Variability in Publically-Prescribed Drug Costs- The Role of Region, Age and Gender

    Nov 1, 2013, 00:00

  • Evidence Thresholds in the Absence of Effective Alternatives- The Case of Intermittent Compression in Critical Limb Ischemia

    Nov 1, 2013, 00:00

  • Addressing Heterogeneity in Baseline Risk of COPD Exacerbations Using Meta-regression

    Nov 1, 2013, 00:00

  • Pharmaceutical Policies, Regulation and Efficiency

    Nov 1, 2013, 00:00

  • Timing of Discharge Makes a Differen The Effects of Length of Stay and Day of Discharge on 30-Day Readmissions

    Nov 1, 2013, 00:00

  • Costos Asociados a Neumonía Severa Y Tuberculosis En Pacientes Con Artritis Reumatoide Que Han Recido Tratamiento Con Terapia Biologica Anti-TNF

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cabazitaxel in mHRPC in Turkey

    Nov 1, 2013, 00:00

  • Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United States

    Nov 1, 2013, 00:00

  • Discrete Event Simulation Model of Primary Prevention of Stroke- Benefits of Increasing Coverage to Unserved Patients

    Nov 1, 2013, 00:00

  • Health Related Quality of Life and Device-Acceptance in Patients with Implantable Cardioverter-Defibrillators and Telemonitoring

    Nov 1, 2013, 00:00

  • Evaluating the Cost-Utility of Fenofibrate Treatment of Diabetic Retinopathy in Australia

    Nov 1, 2013, 00:00

  • Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

    Nov 1, 2013, 00:00

  • Cost-Utility of Dagibatran for Chronic Atrial Fibrillation in Argentina

    Nov 1, 2013, 00:00

  • Quality of Life Outcomes in Multiple Sclerosis- A Review of the Literature

    Nov 1, 2013, 00:00

  • Prevalence of Physicians Causing Potential Drug Interactions in Ambulatory Care in Switzerland- A Representative National Survey

    Nov 1, 2013, 00:00

  • A Guide to Adjusting Survival Time Estimates to Account for Treatment Switching in Randomised Controlled Trials

    Nov 1, 2013, 00:00

  • Comparison of the Health Care Costs and Utilizations Between Patients Diagnosed with the Hepatitis B Virus Versus Those Without

    Nov 1, 2013, 00:00

  • Analysis of Consumption of Diuretics in Serbia from 2006 to 2010

    Nov 1, 2013, 00:00

  • Developing an Individualized E-Health Decision Support System for Dementia Treatment and Care- The FP7 EU-Project E-Health Monitor (EHM)

    Nov 1, 2013, 00:00

  • An Innovative Method- Application of Negative Pressure Wound Therapy in the Treatment of Chronic Leg Ulcers – Medical and Health Economics Aspects

    Nov 1, 2013, 00:00

  • A Review of Clinical Trial Simulation Methods

    Nov 1, 2013, 00:00

  • Estudio De Costo/Utilidad Del Tratamiento Habitual De La Artritis Reumatoidea Mas Etanercept Versus Tratamiento Habitual Más Otros Biológicos Del Mercado Chileno Y Versus Tratamiento Habitual Sin Biológicos

    Nov 1, 2013, 00:00

  • Compared Analysis of Inequalities in Health and Influence of Social Determinants of Health in Cuba and USA

    Nov 1, 2013, 00:00

  • Cost Analysis of Bypassing Agent Prophylaxis Treatment Versus On-Demand Therapy in Hemophilia a with Inhibitor in Spain

    Nov 1, 2013, 00:00

  • HIV Regulatory Practices and Their Influence Over Reimbursement Decisions

    Nov 1, 2013, 00:00

  • The Economics of Reproduction- How ‘Primacy of Succession’ Has Influenced Acceptance and Provision of Assisted Fertility Treatments Throughout History

    Nov 1, 2013, 00:00

  • Estimación Epidemiologica Del Cácer De Pulmón De Celulas No Pequeñas En México

    Nov 1, 2013, 00:00

  • Validity, Responsiveness and Reliability of the Arthritis-Specific Work Productivity Survey Assessing Work Productivity Within and Outside the Home in Patients with Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Patients Preferences Regarding the Treatment of Type II Diabetes Mellitus- Comparison of Best-Worst Scaling and Analytic Hierarchy Process

    Nov 1, 2013, 00:00

  • Racial Disparity in Health Care Access and Outcomes Associated with Prostate Cancer in the United States

    Nov 1, 2013, 00:00

  • The Implications of Demographic Changes for GMS Costs in Ireland Through to 2026

    Nov 1, 2013, 00:00

  • Adherence, Switching, and Discontinuation During the 12 Weeks Following Antidepressant Initiation in Patients with Depressive Disorder- Results of a Prospective, Longitudinal Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Pazopanib as First Line Treatment for Metastatic Renal Cell Carcinoma in Brazil- Updated Analysis

    Nov 1, 2013, 00:00

  • Costs of Prevalence-Based Central Retinal Vein Occlusion (CRVO) in the United Kingdom

    Nov 1, 2013, 00:00

  • The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, Brazil

    Nov 1, 2013, 00:00

  • Confronting Heterogeneity- Using Systematic Review Effectively for Meta-Analysis

    Nov 1, 2013, 00:00

  • Eighty-Nine Local Roche Sponsored French Studies Performed in the Past 10 Years Were Evaluated to Determine How Patient Reported Outcomes Were Used

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Major Depressive Disorder

    Nov 1, 2013, 00:00

  • Dynamic Network Model of Clostridium Difficile Infection to Evaluate Treatment Interventions and Costs

    Nov 1, 2013, 00:00

  • Using Saturn Plots to Describe Co-Morbidity Patterns Within Cohorts

    Nov 1, 2013, 00:00

  • HTA National Public Policy and Their Socio-Economic Environment- A European Perspective

    Nov 1, 2013, 00:00

  • An Economic Model to Compare Linezolid and Vancomycin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

    Nov 1, 2013, 00:00

  • Review of Economic Principles of Branded “Me-Too” Drugs Market

    Nov 1, 2013, 00:00

  • Modelling Staff Resource Use in Ambulatory HIV Care

    Nov 1, 2013, 00:00

  • Use of Calcium Channel Blockers in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Análisis De Impacto Presupuestal Del Uso De Lng Siu Como Método De Contracepción En Colombia

    Nov 1, 2013, 00:00

  • Un Seguro Nacional De Enfermedades Catastróficas- Fundamentos Para Su Implementación

    Nov 1, 2013, 00:00

  • Disease Burden Among Patients with Secondary Progressive Multiple Sclerosis Currently Using Disease Modifying Treatments in Europe Union and the United States

    Nov 1, 2013, 00:00

  • The Use of Preference Based Measures in Haemophilia- Is the Current Evidence Base Useful for Evidence Based Decision Making?

    Nov 1, 2013, 00:00

  • Comparison of Dabigatran Etexilate Versus Warfarin, Asprin No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years

    Nov 1, 2013, 00:00

  • Hospital Resources Consumption Associated with Trastuzumab Treatment in Breast Cancer in Portugal

    Nov 1, 2013, 00:00

  • Mathematical Models of Hepatitis B Vaccination and Screening Programmes in the United Kingdom- A Systematic Review

    Nov 1, 2013, 00:00

  • Hormonal Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC HR+HER2-)- Pre and Post-Progression Costs Under the Public Health Care System (SUS) and Societal Perspectives in Brazil

    Nov 1, 2013, 00:00

  • Indirect Comparison Analysis to Evaluate the Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus Other Treatments for HER2-Positive Metastatic Breast Cancer (MBC)

    Nov 1, 2013, 00:00

  • Holistic Data Generation and Synthesis for HTA Assessment- Bringing Together Comparative Effectiveness Research, Personalised Medicine and Patient-Centred Outcomes Research

    Nov 1, 2013, 00:00

  • Prometex - Promevoz, Tool Support of Pharmaceutical Care for the Scope of Proper Adhesion in Colombia, 2009-2012

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in Russia

    Nov 1, 2013, 00:00

  • The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights- Results from a Survey Among Community Dwelling Long Term Stroke Survivors

    Nov 1, 2013, 00:00

  • Atención Intercultural Del Parto Vaginal En México- Costos Económicos, Determinantes Y Retos De La Implementación De Políticas Efectivas En Beneficio De Las Mujeres Indígenas

    Nov 1, 2013, 00:00

  • An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • An Analysis of the Cost of Switching Renal Transplant Patients from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus Based on Differences in Trough Concentration Variability in the United Kingdom

    Nov 1, 2013, 00:00

  • The Effect of Reduced or Removed Copayments for Prescription Medicines on Adherence – A Systematic Review

    Nov 1, 2013, 00:00

  • Impact of Pill-Splitting Training on Drug Physiochemical Properties, Compliance and Clinical Outcomes in Elderly Population- A Cross-Over Cohort Study

    Nov 1, 2013, 00:00

  • Medico-Economic Evaluation in Fran Methodology and Impact on the Pricing and Reimbursement System

    Nov 1, 2013, 00:00

  • Quality of Life Improvement with Etanercept in Patients with Moderate/Severe Psoriasis from Central and Eastern Europe, Latin America and Asia

    Nov 1, 2013, 00:00

  • Factors Driving Inequality in Prostate Cancer Survival- A Population Based Study

    Nov 1, 2013, 00:00

  • Validating the Unidimensional Fatigue Impact Scale (U-FIS) for Use in Crohn’s Disease

    Nov 1, 2013, 00:00

  • Exploring the Identification of Multiple Sclerosis Incident Cohorts in Claims Databases- Methodology and Challenges

    Nov 1, 2013, 00:00

  • Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Axitinib and Sorafenib for 2nd Line Treatment of Advanced Renal Cell Carcinoma After Failure of Cytokines in the United States

    Nov 1, 2013, 00:00

  • Validation and Psychometric Evaluation of the German-Translated Hepatitis C Virus Patient Reported Outcomes (HCV-PRO) Health and Wellbeing Instrument in German HCV-Infected Patients Treated with Direct Acting Antivirals (DAAS) with or Witho ...

    Nov 1, 2013, 00:00

  • The Funding of Orphan Medicines in Europe- Payers Achilles’ Heel?

    Nov 1, 2013, 00:00

  • Application of Logistic Regression for Signal Detection and Risk Assessment of Macrolide-Associated Torsade De Pointes

    Nov 1, 2013, 00:00

  • Workforce Participation and Productivity Losses After Head and Neck Cancer

    Nov 1, 2013, 00:00

  • Economic Evaluation of Nasogastric Hydration Versus Intravenous Hydration for Infants with Bronchiolitis- A Randomised Trial

    Nov 1, 2013, 00:00

  • Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Measuring Pros That Matter to Bariatric and Body Contouring Surgery- The Body-Q

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Autism Spectrum Disorder

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Breast Cancer Surveillance by Lifetime Risk in Women Aged Less Than 50 Years

    Nov 1, 2013, 00:00

  • Current and Future Strategy for Osteoporosis Screening and Diagnostics- Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on Demand

    Nov 1, 2013, 00:00

  • Custos De Pneumonias Hospitalizadas No Brasil- Análise Comparativa Por Diferentes Métodos De Custeio

    Nov 1, 2013, 00:00

  • Catalogue of EQ-5D Scores for Chronic Conditions in Denmark

    Nov 1, 2013, 00:00

  • A Framework for the Cost-Equality Analysis of Health Care Programmes

    Nov 1, 2013, 00:00

  • Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

    Nov 1, 2013, 00:00

  • ISPOR 16th Annual European Congress Author Index

    Nov 1, 2013, 00:00

  • Evolución Clínica De Una Cohorte De Pacientes Con Enfermedad Renal Crónica Intervenidos En Un Programa De Salud Renal

    Nov 1, 2013, 00:00

  • Cost-Minimization of Mabthera Intravenous Versus Subcutaneous Administration

    Nov 1, 2013, 00:00

  • How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

    Nov 1, 2013, 00:00

  • The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium

    Nov 1, 2013, 00:00

  • Psychosocial Adjustment in Diabetic Patients with and without Diabetic Foot-Ulcers-A Comparative Study

    Nov 1, 2013, 00:00

  • Cost-Of-Illness Study of Patients Subjected to Cardiac Rhythm Management Devices Implantation- Results from a Single Tertiary Centre

    Nov 1, 2013, 00:00

  • How Much Dengue Costs to Brazil? A Retrospective Administrative Claims Analysis from the Public Payer Perspective

    Nov 1, 2013, 00:00

  • Nice STA Decisions- An Analysis of How Advice Differs Between Preliminary and Final Guidance

    Nov 1, 2013, 00:00

  • Health Related Quality of Life (HRQL) in Parkinson’s Disease- The Impact of ‘On’ and ‘Off’ Time

    Nov 1, 2013, 00:00

  • How Do Patients with Chronic Obstructive Pulmonary Disease (COPD) Use Their Inhalers? Common Mistakes. Tecepoc Study

    Nov 1, 2013, 00:00

  • Financial Incentives in Health Care- Evidence of Unintended Consequences

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia

    Nov 1, 2013, 00:00

  • The Notification of Preliminary Investigation (NIP) of the Federal Regulatory Agency of Private Health and Insurance and Plans (ANS)- A Tool to Facilitate the Access to the Mandatory Coverage

    Nov 1, 2013, 00:00

  • Role of Antioxidants in Recurrent Pregnancy Losses, Low Birth Weight, and Gestational Duration

    Nov 1, 2013, 00:00

  • Treatment of Type 2 Diabetes with Saxagliptin/Metformin Extended-Release (XR)- Budget Impact Analysis in Argentina

    Nov 1, 2013, 00:00

  • The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium

    Nov 1, 2013, 00:00

  • Health Economic Analysis of Pneumococcal Vaccination – Example from Bulgaria

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial- Results from Four Major Cities in ...

    Nov 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107 (current)
  • 108
  • 109
  • 110
  • »